Skip to main content

Table 4 Median survivals and 1 year survival rates of MMP-9, TN-C, fTN-C and their co-expressions

From: The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer

Variables

Median survial time (month)

1-year survial rate (%)

Negative

Positive

MMP-9

11

59.3%

32.2%

TN-C

11

54.4%

34.1%

fTN-C

10

58.4%

29.7%

MMP-9+TN-C

9

59.4%

20.4%